Vu Quan Anh, CFO of Monopar Therapeutics ($MNPR), made one open market purchase of shares in the last year, totaling $104,925. His latest buy occurred on December 26, 2025. This ranks 2,101st among 4,983 insiders by purchase value, well below the $1.46 million average across 3.29 transactions. No open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 26, 2025 | Monopar Therapeutics | $MNPR | Vu Quan Anh | Chief Financial Officer | P | Common Stock | 1500 | $69.95 | 1,500.0000 | 6,662,930 | 9999.99% | 0.02% |
| Dec. 2, 2025 | Monopar Therapeutics | $MNPR | Vu Quan Anh | Chief Financial Officer | A | Stock Options | 7135 | $0.00 | 7,135.0000 | 6,662,930 | 9999.99% | 0.11% |
| Dec. 2, 2025 | Monopar Therapeutics | $MNPR | Vu Quan Anh | Chief Financial Officer | A | Restricted Stock Units | 9826 | $0.00 | 9,826.0000 | 6,662,930 | 9999.99% | 0.15% |
| March 3, 2025 | Monopar Therapeutics | $MNPR | Vu Quan Anh | Chief Financial Officer | A | Stock Options | 25000 | $0.00 | 25,000.0000 | 6,102,560 | 9999.99% | 0.41% |